CHA.33490
CyJohnPhos Pd G3
--
--
Ordering
Available Variants250 mg
CHA.33490-250mg
Price
€164.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
250 mg | CHA.33490-250mg | €164.80 |
95%, powder or crystals
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C37H44NO3PPdS |
|---|---|
| CAS Number | 2230788-64-2 |
| Molecular Weight | 720.21 |
| MDL number | MFCD28009175 |
| UNSPSC Code | 12161600 |
| NACRES | NA.22 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
CyJohnPhos Pd G3, with the CAS registry number 2230788-64-2, is a phosphine ligand utilized in various palladium-catalyzed cross-coupling reactions. This ligand has been demonstrated to exhibit high efficiency and selectivity in numerous reactions, including the Suzuki-Miyaura coupling. The unique structural properties of CyJohnPhos Pd G3 enable it to facilitate the formation of complex molecules with high yields and minimal byproduct formation. As a result, this ligand has become a valuable tool in the field of organic synthesis, particularly in the development of pharmaceuticals and materials science. The application of CyJohnPhos Pd G3 has been extensively studied, and its potential for use in a wide range of catalytic reactions continues to be explored, highlighting its significance in modern organic chemistry. Its properties make it an attractive choice for researchers seeking to optimize their synthetic protocols.
